Orient Europharma Co Ltd (4120) — Cash Flow-to-Debt Ratio
Orient Europharma Co Ltd (4120) has a Cash Flow-to-Debt Ratio of -0.03x as of September 2025, meaning its operating cash flow of NT$-157.84 Million could theoretically repay 0% of its total liabilities (NT$4.54 Billion) in one year. Explore Orient Europharma Co Ltd (4120) long-term investment share to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Orient Europharma Co Ltd Cash Flow-to-Debt Ratio (2015–2024)
Historical debt coverage capacity for Orient Europharma Co Ltd across 10 annual periods. Also explore balance sheet size of Orient Europharma Co Ltd for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Orient Europharma Co Ltd (2015–2024)
Year-by-year debt coverage analysis for Orient Europharma Co Ltd. For market capitalisation and broader financial context, see 4120 market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (TWD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.02x | NT$-121.11 Million | NT$5.75 Billion | ▼ -316.7% |
| 2023 | 0.01x | NT$64.67 Million | NT$6.65 Billion | ▲ +131.1% |
| 2022 | -0.03x | NT$-218.75 Million | NT$6.99 Billion | ▼ -339.9% |
| 2021 | 0.01x | NT$77.65 Million | NT$5.95 Billion | ▼ -90.9% |
| 2020 | 0.14x | NT$608.55 Million | NT$4.25 Billion | ▲ +155.5% |
| 2019 | 0.06x | NT$227.37 Million | NT$4.06 Billion | ▼ -25.0% |
| 2018 | 0.07x | NT$231.31 Million | NT$3.10 Billion | ▼ -68.2% |
| 2017 | 0.24x | NT$601.08 Million | NT$2.56 Billion | ▲ +443.4% |
| 2016 | 0.04x | NT$111.24 Million | NT$2.57 Billion | ▼ -86.0% |
| 2015 | 0.31x | NT$643.97 Million | NT$2.09 Billion | — |